$30,000,000 Investor Secured
PolyGenomX is an Australian biotechnology Company whose intellectual property enables it to develop faster growing, higher yielding, more robust and more adaptable plants with the potential to significantly improve the profitability and extend the capabilities of operators in a wide range of industries.
We located an international, Malaysian based investor who offered to inject $15,000,000 in new capital to the business as part of a $30,000,000 total funding package. The remaining funds were offered as a non refundable grant.
In terms of our performance: the offer exceeded the client’s funding requirement by 1500% and the target valuation by 750%.